Side-by-side comparison of AI visibility scores, market position, and capabilities
Account-based marketing and sales intelligence platform that combines intent data, advertising, and CRM enrichment for B2B go-to-market teams.
Demandbase is a San Francisco-based account-based marketing (ABM) company that provides B2B companies with an integrated platform combining first and third-party intent signals, targeted advertising, web personalization, and sales intelligence to identify and engage in-market accounts. The platform helps marketing and sales teams focus resources on accounts that are actively researching solutions rather than spray-and-pray outreach, improving pipeline efficiency. Demandbase's identity resolution technology can identify anonymous website visitors and map them to company accounts, enabling personalized website experiences and precise advertising targeting. The company expanded significantly through acquisitions including Engagio (ABM platform), DemandMatrix (technographic data), and Spiderbook (AI intent), becoming a comprehensive ABM suite. Founded in 2007, Demandbase has raised over $200M from investors including General Atlantic, Adobe, and Sievert Larsen. It competes with 6sense, RollWorks, and Terminus in the ABM platform market serving mid-market and enterprise B2B companies.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.